broggini massimo
broggini massimo
Verified email at marionegri.it
TitleCited byYear
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
MC Garassino, O Martelli, M Broggini, G Farina, S Veronese, E Rulli, ...
The lancet oncology 14 (10), 981-988, 2013
4552013
Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743
M Minuzzo, S Marchini, M Broggini, G Faircloth, M D'Incalci, R Mantovani
Proceedings of the National Academy of Sciences 97 (12), 6780, 2000
2532000
Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy
T Bertani, F Cutillo, C Zoja, M Broggini, G Remuzzi
Kidney Int 30 (4), 488-496, 1986
2491986
Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
C Foroni, M Broggini, D Generali, G Damia
Cancer treatment reviews 38 (6), 689-697, 2012
2242012
PRL-3 phosphatase is implicated in ovarian cancer growth
F Polato, A Codegoni, R Fruscio, P Perego, C Mangioni, S Saha, ...
Clinical Cancer Research 11 (19), 6835-6839, 2005
1952005
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel
D Debernardis, EG Siré, P De Feudis, F Vikhanskaya, M Valenti, P Russo, ...
Cancer research 57 (5), 870, 1997
1821997
Oct‐4 expression in adult human differentiated cells challenges its role as a pure stem cell marker
S Zangrossi, M Marabese, M Broggini, R Giordano, M D'Erasmo, ...
Stem Cells 25 (7), 1675-1680, 2007
1752007
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in …
M Broggini, SV Marchini, E Galliera, P Borsotti, G Taraboletti, E Erba, ...
Leukemia 17 (1), 52, 2003
1502003
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects
T Maffucci, E Piccolo, A Cumashi, M Iezzi, AM Riley, A Saiardi, ...
Cancer research 65 (18), 8339, 2005
1442005
Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer
MC Garassino, M Marabese, P Rusconi, E Rulli, O Martelli, G Farina, ...
Annals of oncology 22 (1), 235-237, 2011
1342011
Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
F Vikhanskaya, MK Lee, M Mazzoletti, M Broggini, K Sabapathy
Nucleic acids research 35 (6), 2093-2104, 2007
1232007
CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers
F Bertoni, AM Codegoni, D Furlan, MG Tibiletti, C Capella, M Broggini
Genes, Chromosomes and Cancer 26 (2), 176-180, 1999
1231999
p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth
M Bonfanti, S Taverna, M Salmona, M D'Incalci, M Broggini
Cancer research 57 (8), 1442-1446, 1997
1231997
Selective DNA interaction of the novel distamycin derivative FCE 24517
M Broggini, E Erba, M Ponti, D Ballinari, C Geroni, F Spreafico, M D'Incalci
Cancer research 51 (1), 199-204, 1991
1221991
Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements
M Broggini, M Ponti, S Ottolenghi, M D'Incalci, N Mongelli, R Mantovani
Nucleic acids research 17 (3), 1051-1059, 1989
1211989
DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin
M Broggini, HM Coley, N Mongelli, E Pesenti, MD Wyatt, JA Hartley, ...
Nucleic acids research 23 (1), 81-87, 1995
1181995
Phospholipase Cγ1 is required for metastasis development and progression
G Sala, F Dituri, C Raimondi, S Previdi, T Maffucci, M Mazzoletti, C Rossi, ...
Cancer research 68 (24), 10187, 2008
1152008
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients.
M Broggini, G Buraggi, A Brenna, L Riva, AM Codegoni, V Torri, ...
Anticancer research 20 (6C), 4835, 2000
1092000
p53 regulates the minimal promoter of the human topoisomerase IIα gene
MI Sandri, RJ Isaacs, WM Ongkeko, AL Harris, ID Hickson, M Broggini, ...
Nucleic acids research 24 (22), 4464-4470, 1996
1081996
Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis
F Vikhanskaya, S Vignati, P Beccaglia, C Ottoboni, P Russo, M D'Incalci, ...
Experimental cell research 241 (1), 96-101, 1998
1051998
The system can't perform the operation now. Try again later.
Articles 1–20